Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer.

por Katsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto, Tomoharu Sugie
Publicado 2021

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.

por Katsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto, Tomoharu Sugie
Publicado 2021

Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab

por Terufumi Yoshida, Hisanori Miki, Hironaga Satake, Toshinori Kobayashi, Yuuki Matsumi, Madoka Hamada, Shogen Boku, Nobuhiro Shibata, Mitsuaki Ishida, Mitsugu Sekimoto
Publicado 2021